Search hospitals > Pennsylvania > Harrisburg
UPMC Pinnacle Cancer Center/Community Osteopathic Campus
Claim this profileHarrisburg, Pennsylvania 17109
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Prostate Cancer
90 reported clinical trials
24 medical researchers
Summary
UPMC Pinnacle Cancer Center/Community Osteopathic Campus is a medical facility located in Harrisburg, Pennsylvania. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Non-Small Cell Lung Cancer, Prostate Cancer and other specialties. UPMC Pinnacle Cancer Center/Community Osteopathic Campus is involved with conducting 90 clinical trials across 133 conditions. There are 24 research doctors associated with this hospital, such as Liza C. Villaruz, Adam Brufsky, MD, Dan P. Zandberg, and Alexander B. Olawaiye.Area of expertise
1Breast Cancer
Global LeaderStage IV
ER positive
HER2 negative
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Liza C. VillaruzUniversity of Pittsburgh Cancer Institute (UPCI)6 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
40 reported clinical trials
59 drugs studied
Adam Brufsky, MDUniversity of Pittsburgh Cancer Institute (UPCI)2 years of reported clinical research
Expert in Breast Cancer
Expert in Breast cancer
31 reported clinical trials
70 drugs studied
Dan P. ZandbergUniversity of Pittsburgh Cancer Institute (UPCI)4 years of reported clinical research
Expert in Squamous Cell Carcinoma
Studies Head and Neck Squamous Cell Carcinoma
20 reported clinical trials
36 drugs studied
Alexander B. OlawaiyeUniversity of Pittsburgh Cancer Institute (UPCI)3 years of reported clinical research
Expert in Ovarian Cancer
Studies Fallopian Tube Cancer
21 reported clinical trials
45 drugs studied
Clinical Trials running at UPMC Pinnacle Cancer Center/Community Osteopathic Campus
Lung Cancer
Prostate Cancer
Breast Cancer
Bladder Cancer
Laryngeal Cancer
Breast cancer
Oropharyngeal Carcinoma
Throat Cancer
Squamous Cell Carcinoma
Non-Small Cell Lung Cancer
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Stereotactic Radiosurgery vs Whole-Brain Radiotherapy
for Brain Metastasis from Lung Cancer
This phase III trial compares the effect of stereotactic radiosurgery to standard of care memantine and whole brain radiation therapy that avoids the hippocampus (the memory zone of the brain) for the treatment of small cell lung cancer that has spread to the brain. Stereotactic radiosurgery is a specialized radiation therapy that delivers a single, high dose of radiation directly to the tumor and may cause less damage to normal tissue. Whole brain radiation therapy delivers a low dose of radiation to the entire brain including the normal brain tissue. Hippocampal avoidance during whole-brain radiation therapy (HA-WBRT) decreases the amount of radiation that is delivered to the hippocampus which is a brain structure that is important for memory. The drug, memantine, is also often given with whole brain radiotherapy because it may decrease the risk of side effects related to thinking and memory. Stereotactic radiosurgery may decrease side effects related to memory and thinking compared to standard of care HA-WBRT plus memantine.
Recruiting2 awards Phase 315 criteria
Durvalumab
for Lung Cancer
This phase III trial compares durvalumab to the usual approach (patient observation) after surgery for the treatment of patients with early-stage non-small cell lung cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The usual approach for patients who are not in a study is to closely watch a patient's condition after surgery and to have regular visits with their doctor to watch for signs of the cancer coming back. Usually, patients do not receive further treatment unless the cancer returns. This study will help determine whether this different approach with durvalumab is better, the same, or worse than the usual approach of observation. Giving durvalumab may help patients live longer and prevent early-stage non-small cell lung cancer from coming back as compared to the usual approach.
Recruiting2 awards Phase 38 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at UPMC Pinnacle Cancer Center/Community Osteopathic Campus?
UPMC Pinnacle Cancer Center/Community Osteopathic Campus is a medical facility located in Harrisburg, Pennsylvania. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Non-Small Cell Lung Cancer, Prostate Cancer and other specialties. UPMC Pinnacle Cancer Center/Community Osteopathic Campus is involved with conducting 90 clinical trials across 133 conditions. There are 24 research doctors associated with this hospital, such as Liza C. Villaruz, Adam Brufsky, MD, Dan P. Zandberg, and Alexander B. Olawaiye.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.